ARQIS has advised biotech company Emergence Therapeutics AG on the deal, while Horn&Co. advised Pontifax Ventures 6. J&A advised Bpifrance. Weitnauer advised NRW.BANK. The round was...
Emergence Therapeutics’ Series A Financing Round
Oxurion’s Funding Round
Horn & Co. represented Pontifax Ventures on the deal. Pontifax Venture Capital and Kreos Capital provided €10 million debt financing to Oxurion. Oxurion is focused on...